Occudo Quantitative Strategies’s Repare Therapeutics RPTX Stock Holding History

Occudo Quantitative Strategies’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,548	Closed	-$35.2K	–	898
2025 Q4	$35.2K	Buy	+13,548	New	+$27.3K	﹤0.01%	669
2024 Q2	–	Sell	-15,443	Closed	-$72.7K	–	962
2024 Q1	$72.7K	Sell	15,443 -15,386	-50%	-$98.6K	0.01%	677
2023 Q4	$225K	Buy	+30,829	New	+$172K	0.03%	623

Occudo Quantitative Strategies's RPTX Position: Q1 2026 in Review

Occudo Quantitative Strategies sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 13,548 shares — an estimated $35.2K sold.

Occudo Quantitative Strategies first reported a position in RPTX in Q4 2023 and held it in 3 quarters. The position peaked at $225K in Q4 2023. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.

Occudo Quantitative Strategies reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
Occudo Quantitative Strategies sold 13,548 Repare Therapeutics shares in Q1 2026, an estimated $35.2K.
Occudo Quantitative Strategies first reported a position in Repare Therapeutics in Q4 2023 and held it in 3 quarters.
Occudo Quantitative Strategies's Repare Therapeutics position peaked at $225K in Q4 2023.
0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2026, filed 15 May 2026.